Previously, we reported greater agreement between postmortem neuronal tau covariance and tau PET covariance than between astrocytic and oligodendroglial tau covariance in the same samples from patients with PSP [19]. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.